Home / Topics / TEVIMBRA

TEVIMBRA Podcasts

1 episode about TEVIMBRA

BeOne Medicines AG Announced Q4 2025 Earnings on February 26, 2026, Reporting "Product revenue reached $1.5 billion in the fourth quarter". artwork

BeOne Medicines AG Announced Q4 2025 Earnings on February 26, 2026, Reporting "Product revenue reached $1.5 billion in the fourth quarter".
BeOne Medicines AG (ONC)
• 10:46 •Ep 37 •The Earnings Debate •▶ Play on Apple